BOUNDLESS BIO, INC. Depreciation and Amortization
BOUNDLESS BIO, INC. (BOLD) reported Depreciation and Amortization of $1.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-07
- BOUNDLESS BIO, INC. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $1.26M, a 296.53% increase year-over-year.
- BOUNDLESS BIO, INC. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $284.00K, a 10.41% decline year-over-year.
- BOUNDLESS BIO, INC. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $307.00K, a 3.72% increase year-over-year.
- BOUNDLESS BIO, INC. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $310.00K, a 18.32% increase year-over-year.
- BOUNDLESS BIO, INC. depreciation, depletion and amortization for fiscal 2025 was $1.25M, a 15.19% increase from fiscal 2024.
- BOUNDLESS BIO, INC. depreciation, depletion and amortization for fiscal 2024 was $1.09M, a 13.48% increase from fiscal 2023.
- BOUNDLESS BIO, INC. depreciation, depletion and amortization for fiscal 2023 was $957.00K.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.54M 10-Q · filed 2026-08-07 | $1.85M derived: sum of 3 quarters · filed 2026-08-07 | $2.16M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $284.00K 10-Q · filed 2026-05-08 | $591.00K derived: sum of 2 quarters · filed 2026-05-08 | $901.00K derived: sum of 3 quarters · filed 2026-05-08 | $1.22M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $307.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $617.00K derived: sum of 2 quarters · filed 2026-03-09 | $934.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.25M 10-K · filed 2026-03-09 |
| 2025-09-30 | $310.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $627.00K derived: sum of 2 quarters · filed 2026-08-07 | $944.00K 10-Q · filed 2025-11-05 | $1.24M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $317.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $634.00K 10-Q · filed 2026-08-07 | $930.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.19M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $317.00K 10-Q · filed 2026-05-08 | $613.00K derived: sum of 2 quarters · filed 2026-05-08 | $875.00K derived: sum of 3 quarters · filed 2026-05-08 | $1.14M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $296.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $558.00K derived: sum of 2 quarters · filed 2026-03-09 | $823.00K derived: sum of 3 quarters · filed 2026-03-09 | $1.09M 10-K · filed 2026-03-09 |
| 2024-09-30 | $262.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $527.00K derived: sum of 2 quarters · filed 2025-11-05 | $790.00K 10-Q · filed 2025-11-05 | $1.04M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $265.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $528.00K 10-Q · filed 2025-08-05 | $775.00K derived: sum of 3 quarters · filed 2025-08-05 | |
| 2024-03-31 | $263.00K 10-Q · filed 2025-05-09 | $510.00K derived: sum of 2 quarters · filed 2025-05-09 | ||
| 2023-12-31 | $247.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $957.00K 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $710.00K 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |